Randomized immunotherapy trial in dual‐allergic patients using “active allergen placebo” as control

BACKGROUND: Placebo control in allergen immunotherapy (AIT) trials presents ethical and blinding concerns. We tested a trial design with an “active allergen placebo,” as proposed by ARIA‐GA (2) LEN, to investigate in a double‐blind trial the efficacy and safety of AIT in dual‐allergic patients (gras...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagenmann, Martin, Worm, Margitta, Akboga, Yasemin, Karjalainen, Martin, Hohlfeld, Jens M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773203/
https://www.ncbi.nlm.nih.gov/pubmed/31025363
http://dx.doi.org/10.1111/all.13842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773203/
https://www.ncbi.nlm.nih.gov/pubmed/31025363
http://dx.doi.org/10.1111/all.13842

Ejemplares similares